Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Gastric Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 161 articles:
HTML format
Text format



Single Articles


    May 2018
  1. YANG L, Yang G, Ding Y, Huang Y, et al
    Combined treatment with PI3K inhibitor BKM120 and PARP inhibitor olaparib is effective in inhibiting the gastric cancer cells with ARID1A deficiency.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6445.
    PubMed     Text format     Abstract available


  2. XIN J, Wang S, Zhang L, Xin B, et al
    Comparison of the synergistic anticancer activity of AlPcS4 photodynamic therapy in combination with different lowdose chemotherapeutic agents on gastric cancer cells.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6438.
    PubMed     Text format     Abstract available


  3. KUMATA Y, Iinuma H, Suzuki Y, Tsukahara D, et al
    Exosomeencapsulated microRNA23b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6418.
    PubMed     Text format     Abstract available


  4. XU G, Meng L, Yuan D, Li K, et al
    MEG3/miR21 axis affects cell mobility by suppressing epithelialmesenchymal transition in gastric cancer.
    Oncol Rep. 2018 May 8. doi: 10.3892/or.2018.6424.
    PubMed     Text format     Abstract available


  5. WANG W, Liu J, Qi J, Zhang J, et al
    [Corrigendum] RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.
    Oncol Rep. 2018;39:2450.
    PubMed     Text format     Abstract available


    April 2018
  6. WANG Y, Zhang H, Ge S, Fan Q, et al
    Effects of miR1385p and miR2045p on the migration and proliferation of gastric cancer cells by targeting EGFR.
    Oncol Rep. 2018 Apr 23. doi: 10.3892/or.2018.6389.
    PubMed     Text format     Abstract available


  7. SHEN J, Li M, Min L
    HSPB8 promotes cancer cell growth by activating the ERKCREB pathway and is indicative of a poor prognosis in gastric cancer patients.
    Oncol Rep. 2018 Apr 18. doi: 10.3892/or.2018.6376.
    PubMed     Text format     Abstract available


  8. ZHANG YZ, Wang CF, Zhang LF
    Cucurbitacin D impedes gastric cancer cell survival via activation of the iNOS/NO and inhibition of the Akt signalling pathway.
    Oncol Rep. 2018 Apr 10. doi: 10.3892/or.2018.6361.
    PubMed     Text format     Abstract available


    March 2018
  9. FU ZH, Liu SQ, Qin MB, Huang JA, et al
    NIK and IKKbetabinding protein contributes to gastric cancer chemoresistance by promoting epithelialmesenchymal transition through the NFkappaB signaling pathway.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6348.
    PubMed     Text format     Abstract available


  10. SU B, Su J, Zeng Y, Ding E, et al
    Diallyl disulfide inhibits TGFbeta1induced upregulation of Rac1 and betacatenin in epithelialmesenchymal transition and tumor growth of gastric cancer.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6345.
    PubMed     Text format     Abstract available


  11. XU J, Gong L, Qian Z, Song G, et al
    ERBB4 promotes the proliferation of gastric cancer cells via the PI3K/Akt signaling pathway.
    Oncol Rep. 2018 Mar 30. doi: 10.3892/or.2018.6343.
    PubMed     Text format     Abstract available


  12. LUO Y, Chen X, Luo L, Zhang Q, et al
    [6]-Gingerol enhances the radiosensitivity of gastric cancer via G2/M phase arrest and apoptosis induction.
    Oncol Rep. 2018 Mar 5. doi: 10.3892/or.2018.6292.
    PubMed     Text format     Abstract available


  13. SUN JH, Li XL, Yin J, Li YH, et al
    A screening method for gastric cancer by oral microbiome detection.
    Oncol Rep. 2018 Mar 1. doi: 10.3892/or.2018.6286.
    PubMed     Text format     Abstract available


    February 2018
  14. SONG J, Ma SJ, Luo JH, Zhang H, et al
    Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway.
    Oncol Rep. 2018 Feb 26. doi: 10.3892/or.2018.6282.
    PubMed     Text format     Abstract available


  15. WANG Q, Yang H, Zhuo Q, Xu Y, et al
    Knockdown of EPCR inhibits the proliferation and migration of human gastric cancer cells via the ERK1/2 pathway in a PAR-1-dependent manner.
    Oncol Rep. 2018 Feb 21. doi: 10.3892/or.2018.6276.
    PubMed     Text format     Abstract available


  16. CHEN Y, Liu J, Wang W, Xiang L, et al
    High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
    Oncol Rep. 2018 Feb 16. doi: 10.3892/or.2018.6273.
    PubMed     Text format     Abstract available


  17. GAO XY, Li L, Wang XH, Wen XZ, et al
    [Corrigendum] Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
    Oncol Rep. 2018 Feb 14. doi: 10.3892/or.2018.6269.
    PubMed     Text format     Abstract available


  18. YAN H, Qiu C, Sun W, Gu M, et al
    Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6252.
    PubMed     Text format     Abstract available


  19. CHEN JW, Luo YJ, Yang ZF, Wen LQ, et al
    Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6253.
    PubMed     Text format     Abstract available


  20. ZHAO J, Geng L, Duan G, Xu W, et al
    REC8 inhibits EMT by downregulating EGR1 in gastric cancer cells.
    Oncol Rep. 2018 Feb 1. doi: 10.3892/or.2018.6244.
    PubMed     Text format     Abstract available


    January 2018
  21. XIONG J, Han S, Ding S, He J, et al
    Antibody-nanoparticle conjugate constructed with trastuzumab and nanoparticle albumin-bound paclitaxel for targeted therapy of human epidermal growth factor receptor 2-positive gastric cancer.
    Oncol Rep. 2018 Jan 9. doi: 10.3892/or.2018.6201.
    PubMed     Text format     Abstract available


  22. FAN H, Jiang M, Li B, He Y, et al
    MicroRNA-let-7a regulates cell autophagy by targeting Rictor in gastric cancer cell lines MGC-803 and SGC-7901.
    Oncol Rep. 2018 Jan 5. doi: 10.3892/or.2018.6194.
    PubMed     Text format     Abstract available


  23. TANG Q, Wang Y, Ma L, Ding M, et al
    Peiminine serves as an adriamycin chemosensitizer in gastric cancer by modulating the EGFR/FAK pathway.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6184.
    PubMed     Text format     Abstract available


    December 2017
  24. WANG X, Liu B, Wen F, Song Y, et al
    MicroRNA-454 inhibits the malignant biological behaviours of gastric cancer cells by directly targeting mitogen-activated protein kinase 1.
    Oncol Rep. 2017 Dec 20. doi: 10.3892/or.2017.6171.
    PubMed     Text format     Abstract available


  25. HUANG Y, Zhu J, Li W, Zhang Z, et al
    Serum microRNA panel excavated by machine learning as a potential biomarker for the detection of gastric cancer.
    Oncol Rep. 2017 Dec 19. doi: 10.3892/or.2017.6163.
    PubMed     Text format     Abstract available


  26. WU J, Zhang X, Wang Y, Sun Q, et al
    Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway.
    Oncol Rep. 2017 Dec 14. doi: 10.3892/or.2017.6155.
    PubMed     Text format     Abstract available


    November 2017
  27. KURATA A, Yamada M, Ohno SI, Inoue S, et al
    Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
    Oncol Rep. 2017 Nov 10. doi: 10.3892/or.2017.6093.
    PubMed     Text format     Abstract available


  28. LIAN G, Li L, Ye F, Wang D, et al
    The screening and analysis of protein signatures and signaling associated with chemoresistance based on Protein Pathway Array technology in gastric cancer.
    Oncol Rep. 2017 Nov 6. doi: 10.3892/or.2017.6078.
    PubMed     Text format     Abstract available


    October 2017
  29. LI Y, Wang K, Wei Y, Yao Q, et al
    lncRNA-MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR-29a-3p/HDAC4 axis.
    Oncol Rep. 2017 Oct 10. doi: 10.3892/or.2017.6020.
    PubMed     Text format     Abstract available


    September 2017
  30. FENG A, Yuan X, Li X
    MicroRNA-345 inhibits metastasis and epithelial-mesenchymal transition of gastric cancer by targeting FOXQ1.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6001.
    PubMed     Text format     Abstract available


  31. REN QG, Yang SL, Li PD, Xiong JR, et al
    Low heme oxygenase-1 expression promotes gastric cancer cell apoptosis, inhibits proliferation and invasion, and correlates with increased overall survival in gastric cancer patients.
    Oncol Rep. 2017 Sep 19. doi: 10.3892/or.2017.5967.
    PubMed     Text format     Abstract available


  32. CHENG Y, Jia B, Wang Y, Wan S, et al
    miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARgamma in gastric cancer.
    Oncol Rep. 2017 Sep 7. doi: 10.3892/or.2017.5944.
    PubMed     Text format     Abstract available


  33. ZHANG W, Gu J, Chen J, Zhang P, et al
    Interaction with neutrophils promotes gastric cancer cell migration and invasion by inducing epithelial-mesenchymal transition.
    Oncol Rep. 2017 Sep 6. doi: 10.3892/or.2017.5942.
    PubMed     Text format     Abstract available


    August 2017
  34. WANG P, Ma M, Zhang S
    EGF-induced urokinase plasminogen activator receptor promotes epithelial to mesenchymal transition in human gastric cancer cells.
    Oncol Rep. 2017 Aug 24. doi: 10.3892/or.2017.5920.
    PubMed     Text format     Abstract available


  35. XU D, Shao W, Jiang Y, Wang X, et al
    FTO expression is associated with the occurrence of gastric cancer and prognosis.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5904.
    PubMed     Text format     Abstract available


  36. WANG X, Fu R, Hu Y, Du H, et al
    EGFR gene status predicts response and survival benefit in a preclinical gastric cancer trial treating patientderived xenografts with cetuximab.
    Oncol Rep. 2017 Aug 14. doi: 10.3892/or.2017.5907.
    PubMed     Text format     Abstract available


  37. GUO J, Yan Y, Yan Y, Guo Q, et al
    Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
    Oncol Rep. 2017 Aug 3. doi: 10.3892/or.2017.5877.
    PubMed     Text format     Abstract available


    July 2017
  38. CHEN T, Huang Z, Tian Y, Wang H, et al
    Role of triosephosphate isomerase and downstream functional genes on gastric cancer.
    Oncol Rep. 2017 Jul 24. doi: 10.3892/or.2017.5846.
    PubMed     Text format     Abstract available


  39. JI R, Zhang X, Qian H, Gu H, et al
    miR-374 mediates the malignant transformation of gastric cancer-associated mesenchymal stem cells in an experimental rat model.
    Oncol Rep. 2017 Jul 18. doi: 10.3892/or.2017.5831.
    PubMed     Text format     Abstract available


  40. TAO Y, Sun C, Zhang T, Song Y, et al
    SMURF1 promotes the proliferation, migration and invasion of gastric cancer cells.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5825.
    PubMed     Text format     Abstract available


  41. CHEN T, Wang K, Tong X
    In vivo and in vitro inhibition of human gastric cancer progress by upregulating Kank1 gene.
    Oncol Rep. 2017 Jul 17. doi: 10.3892/or.2017.5823.
    PubMed     Text format     Abstract available


  42. GONG YC, Ren GL, Liu B, Li F, et al
    miR206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
    Oncol Rep. 2017 Jul 6. doi: 10.3892/or.2017.5794.
    PubMed     Text format     Abstract available


  43. YUAN X, Zhang T, Zheng X, Zhang Y, et al
    Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
    Oncol Rep. 2017 Jul 4. doi: 10.3892/or.2017.5788.
    PubMed     Text format     Abstract available


    June 2017
  44. ZHOU J, Wu A, Yu X, Zhu J, et al
    SIRT6 inhibits growth of gastric cancer by inhibiting JAK2/STAT3 pathway.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5753.
    PubMed     Text format     Abstract available


  45. GE F, Wang C, Wang W, Liu W, et al
    MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Oncol Rep. 2017 Jun 27. doi: 10.3892/or.2017.5758.
    PubMed     Text format     Abstract available


  46. CHEN X, Yuan LQ, Li LJ, Lv Y, et al
    Suppression of gastric cancer by extract from the tuber of amorphophallus konjac via induction of apoptosis and autophagy.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5747.
    PubMed     Text format     Abstract available


  47. PANG L, Li B, Zheng B, Niu L, et al
    miR-138 inhibits gastric cancer growth by suppressing SOX4.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5745.
    PubMed     Text format     Abstract available


  48. TIAN W, Shen J, Chen W
    Suppression of midkine gene promotes the antitumoral effect of cisplatin on human gastric cancer cell line AGS in vitro and in vivo via the modulation of Notch signaling pathway.
    Oncol Rep. 2017 Jun 22. doi: 10.3892/or.2017.5743.
    PubMed     Text format     Abstract available


  49. LIU J, Li Y, Zou Y, Zhang J, et al
    MicroRNA-497 acts as a tumor suppressor in gastric cancer and is downregulated by DNA methylation.
    Oncol Rep. 2017 Jun 6. doi: 10.3892/or.2017.5698.
    PubMed     Text format     Abstract available


  50. BAI L, Guo CH, Zhao Y, Gao JG, et al
    SUVmax of 18F-FDG PET/CT correlates to expression of major chemotherapy-related tumor markers and serum tumor markers in gastric adenocarcinoma patients.
    Oncol Rep. 2017;37:3433-3440.
    PubMed     Text format     Abstract available


    May 2017
  51. ZHAO C, Li Y, Chen G, Wang F, et al
    Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
    Oncol Rep. 2017 May 26. doi: 10.3892/or.2017.5673.
    PubMed     Text format     Abstract available


  52. NING T, Zhang H, Wang X, Li S, et al
    miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer.
    Oncol Rep. 2017 May 23. doi: 10.3892/or.2017.5660.
    PubMed     Text format     Abstract available


  53. NING T, Peng Z, Li S, Qu Y, et al
    miR-455 inhibits cell proliferation and migration via negative regulation of EGFR in human gastric cancer.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5657.
    PubMed     Text format     Abstract available


  54. JIANG T, Dong P, Li L, Ma X, et al
    MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Oncol Rep. 2017 May 22. doi: 10.3892/or.2017.5659.
    PubMed     Text format     Abstract available


  55. LIU X, Duan C, Ji J, Zhang T, et al
    Cucurbitacin B induces autophagy and apoptosis by suppressing CIP2A/PP2A/mTORC1 signaling axis in human cisplatin resistant gastric cancer cells.
    Oncol Rep. 2017 May 18. doi: 10.3892/or.2017.5648.
    PubMed     Text format     Abstract available


  56. LI LH, Wu GY, Lu YZ, Chen XH, et al
    p21-activated protein kinase 1 induces the invasion of gastric cancer cells through c-Jun NH2-terminal kinase-mediated activation of matrix metalloproteinase-2.
    Oncol Rep. 2017 May 16. doi: 10.3892/or.2017.5643.
    PubMed     Text format     Abstract available


  57. RAO M, Zhu Y, Cong X, Li Q, et al
    Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5636.
    PubMed     Text format     Abstract available


  58. LI W, Zhou Y, Yang J, Li H, et al
    Curcumin induces apoptotic cell death and protective autophagy in human gastric cancer cells.
    Oncol Rep. 2017 May 11. doi: 10.3892/or.2017.5637.
    PubMed     Text format     Abstract available


  59. LI X, Li J, Li F
    P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion.
    Oncol Rep. 2017;37:2857-2864.
    PubMed     Text format     Abstract available


    April 2017
  60. JIN JJ, Dai FX, Long ZW, Cai H, et al
    CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Oncol Rep. 2017 Apr 25. doi: 10.3892/or.2017.5598.
    PubMed     Text format     Abstract available


  61. YAMAGUCHI T, Fushida S, Yamamoto Y, Tsukada T, et al
    Low-dose paclitaxel suppresses the induction of M2 macrophages in gastric cancer.
    Oncol Rep. 2017 Apr 19. doi: 10.3892/or.2017.5586.
    PubMed     Text format     Abstract available


    March 2017
  62. DUAN J, Chen L, Zhou M, Zhang J, et al
    MACC1 decreases the chemosensitivity of gastric cancer cells to oxaliplatin by regulating FASN expression.
    Oncol Rep. 2017 Mar 22. doi: 10.3892/or.2017.5519.
    PubMed     Text format     Abstract available


  63. WANG Y, Xiao H, Wu H, Yao C, et al
    G protein subunit alpha q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5500.
    PubMed     Text format     Abstract available


  64. LIU Y, Sun Y, Zhao A
    MicroRNA-134 suppresses cell proliferation in gastric cancer cells via targeting of GOLPH3.
    Oncol Rep. 2017 Mar 2. doi: 10.3892/or.2017.5488.
    PubMed     Text format     Abstract available


  65. SUI W, Shi Z, Xue W, Ou M, et al
    Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
    Oncol Rep. 2017;37:1804-1814.
    PubMed     Text format     Abstract available


  66. YU J, Wang X, Li Y, Tang B, et al
    Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1.
    Oncol Rep. 2017;37:1394-1400.
    PubMed     Text format     Abstract available


    February 2017
  67. TAMAKI R, Kanai-Mori A, Morishige Y, Koike A, et al
    Effects of 5-fluorouracil, adriamycin and irinotecan on HSC-39, a human scirrhous gastric cancer cell line.
    Oncol Rep. 2017 Feb 20. doi: 10.3892/or.2017.5470.
    PubMed     Text format     Abstract available


  68. WANG J, Zhou Y, Fei X, Chen X, et al
    ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126.
    Oncol Rep. 2017 Feb 16. doi: 10.3892/or.2017.5460.
    PubMed     Text format     Abstract available


  69. SUN DP, Fang CL, Chen HK, Wen KS, et al
    EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5442.
    PubMed     Text format     Abstract available


  70. WANG L, Huang X, Chai Y, Zou L, et al
    Octreotide inhibits the proliferation of gastric cancer cells through P300-HAT activity and the interaction of ZAC and P300.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5451.
    PubMed     Text format     Abstract available


  71. HUANG Y, Li X, Sha H, Zhang L, et al
    Tumor-penetrating peptide fused to a pro-apoptotic peptide facilitates effective gastric cancer therapy.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5440.
    PubMed     Text format     Abstract available


    January 2017
  72. XIE R, Wang H, Jin H, Wen G, et al
    NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
    Oncol Rep. 2017 Jan 18. doi: 10.3892/or.2017.5386.
    PubMed     Text format     Abstract available


  73. CAO W, Wei W, Zhan Z, Xie D, et al
    Role of miR-647 in human gastric cancer suppression.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5383.
    PubMed     Text format     Abstract available


  74. LI C, Lu S, Shi Y
    MicroRNA-187 promotes growth and metastasis of gastric cancer by inhibiting FOXA2.
    Oncol Rep. 2017 Jan 16. doi: 10.3892/or.2017.5370.
    PubMed     Text format     Abstract available


  75. LI A, Li J, Lin J, Zhuo W, et al
    COL11A1 is overexpressed in gastric cancer tissues and regulates proliferation, migration and invasion of HGC-27 gastric cancer cells in vitro.
    Oncol Rep. 2017;37:333-340.
    PubMed     Text format     Abstract available


    December 2016
  76. TANG C, Gong L, Zou W, Zhang J, et al
    Multivariate analysis of metastasisrelated risk factors for patients with gastroenteropancreatic neuroendocrine tumors based on clinicopathological and endoscopic features.
    Oncol Rep. 2016;36:3343-3352.
    PubMed     Text format     Abstract available


    November 2016
  77. LI W, Wang Z, Zha L, Kong D, et al
    HMGA2 regulates epithelial-mesenchymal transition and the acquisition of tumor stem cell properties through TWIST1 in gastric cancer.
    Oncol Rep. 2016 Nov 18. doi: 10.3892/or.2016.5255.
    PubMed     Text format     Abstract available


  78. YANG C, Gao J, Yan N, Wu B, et al
    Propofol inhibits the growth and survival of gastric cancer cells in vitro through the upregulation of ING3.
    Oncol Rep. 2016 Nov 4. doi: 10.3892/or.2016.5218.
    PubMed     Text format     Abstract available


  79. LU X, Ma J, Qiu H, Yang L, et al
    Anti-proliferation effects of trifolirhizin on MKN45 cells and possible mechanism.
    Oncol Rep. 2016;36:2785-2792.
    PubMed     Text format     Abstract available


    October 2016
  80. ZHANG J, Zhu JS, Zhou Z, Chen WX, et al
    [Retracted] Inhibitory effects of ethyl pyruvate administration on human gastric cancer growth via regulation of the HMGB1-RAGE and Akt pathways in vitro and in vivo.
    Oncol Rep. 2016 Oct 19. doi: 10.3892/or.2016.5181.
    PubMed     Text format     Abstract available


  81. CHEN B, Zhao J, Zhang S, Zhang Y, et al
    HPIP promotes gastric cancer cell proliferation through activation of cap-dependent translation.
    Oncol Rep. 2016 Oct 11. doi: 10.3892/or.2016.5157.
    PubMed     Text format     Abstract available


  82. FENG S, Zheng Z, Feng L, Yang L, et al
    Proton pump inhibitor pantoprazole inhibits the proliferation, selfrenewal and chemoresistance of gastric cancer stem cells via the EMT/betacatenin pathways.
    Oncol Rep. 2016 Oct 7. doi: 10.3892/or.2016.5154.
    PubMed     Text format     Abstract available


  83. CHEN SY, Zhang RG, Duan GC
    Pathogenic mechanisms of the oncoprotein CagA in H. pylori-induced gastric cancer (Review).
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5145.
    PubMed     Text format     Abstract available


    September 2016
  84. HUANG T, Zhou F, Wang-Johanning F, Nan K, et al
    Depression accelerates the development of gastric cancer through reactive oxygen speciesactivated ABL1 (Review).
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5127.
    PubMed     Text format     Abstract available


  85. XU H, Peng JG, Zhuang YF, Chen JJ, et al
    Establishment and characterization of an expanding-type gastric cancer cell line by Ming's classification.
    Oncol Rep. 2016 Sep 14. doi: 10.3892/or.2016.5090.
    PubMed     Text format     Abstract available


  86. LI J, Gao X, Ji K, Sanders AJ, et al
    Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression.
    Oncol Rep. 2016 Sep 8. doi: 10.3892/or.2016.5074.
    PubMed     Text format     Abstract available


  87. BU X, Li M, Zhao Y, Liu S, et al
    Genetically engineered Newcastle disease virus expressing human interferon-lambda1 induces apoptosis in gastric adenocarcinoma cells and modulates the Th1/Th2 immune response.
    Oncol Rep. 2016;36:1393-402.
    PubMed     Text format     Abstract available


    August 2016
  88. OKUGAWA Y, Mohri Y, Tanaka K, Kawamura M, et al
    Metastasis-associated protein is a predictive biomarker for metastasis and recurrence in gastric cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5054.
    PubMed     Text format     Abstract available


  89. WANG W, Liu J, Qi J, Zhang J, et al
    RLIP76 increases apoptosis through Akt/mTOR signaling pathway in gastric cancer.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5043.
    PubMed     Text format     Abstract available


  90. XIONG J, Li Z, Zhang Y, Li D, et al
    PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
    Oncol Rep. 2016 Aug 23. doi: 10.3892/or.2016.5030.
    PubMed     Text format     Abstract available


  91. WANG H, Xiong M, Hu Y, Sun Y, et al
    MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3.
    Oncol Rep. 2016 Aug 23. doi: 10.3892/or.2016.5029.
    PubMed     Text format     Abstract available


  92. ZHANG Z, Kong Y, Yang W, Ma F, et al
    Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5016.
    PubMed     Text format     Abstract available


  93. DONG S, Xia J, Wang H, Sun L, et al
    Overexpression of TRIB3 promotes angiogenesis in human gastric cancer.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5017.
    PubMed     Text format     Abstract available


  94. LI Y, Nie Y, Tu S, Wang H, et al
    Epigenetically deregulated miR-200c is involved in a negative feedback loop with DNMT3a in gastric cancer cells.
    Oncol Rep. 2016 Aug 2. doi: 10.3892/or.2016.4996.
    PubMed     Text format     Abstract available


  95. KONG Y, Zheng Y, Jia Y, Li P, et al
    Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
    Oncol Rep. 2016 Aug 1. doi: 10.3892/or.2016.4989.
    PubMed     Text format     Abstract available


    July 2016
  96. JIANG Z, Liu Z, Zou S, Ni J, et al
    Transcription factor c-jun regulates beta3Gn-T8 expression in gastric cancer cell line SGC-7901.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4959.
    PubMed     Text format     Abstract available


  97. YANG C, Zheng W, Du W
    CXCR3A contributes to the invasion and metastasis of gastric cancer cells.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4953.
    PubMed     Text format     Abstract available


  98. ZHUANG K, Yan Y, Zhang X, Zhang J, et al
    Gastrin promotes the metastasis of gastric carcinoma through the beta-catenin/TCF-4 pathway.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4943.
    PubMed     Text format     Abstract available


    June 2016
  99. XIE M, Dart DA, Owen S, Wen X, et al
    Insights into roles of the miR-1, -133 and -206 family in gastric cancer (Review).
    Oncol Rep. 2016 Jun 27. doi: 10.3892/or.2016.4908.
    PubMed     Text format     Abstract available


  100. YANG M, Qu Y, Shi R, Wu X, et al
    Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer.
    Oncol Rep. 2016 Jun 23. doi: 10.3892/or.2016.4906.
    PubMed     Text format     Abstract available


  101. YIN G, Zhou H, Xue Y, Yao B, et al
    MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
    Oncol Rep. 2016 Jun 15. doi: 10.3892/or.2016.4876.
    PubMed     Text format     Abstract available


  102. SU CC, Chiu TL
    Tanshinone IIA decreases the protein expression of EGFR, and IGFR blocking the PI3K/Akt/mTOR pathway in gastric carcinoma AGS cells both in vitro and in vivo.
    Oncol Rep. 2016 Jun 7. doi: 10.3892/or.2016.4857.
    PubMed     Text format     Abstract available


  103. CAO X, Ren K, Song Z, Li D, et al
    7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells.
    Oncol Rep. 2016 Jun 2. doi: 10.3892/or.2016.4848.
    PubMed     Text format     Abstract available


  104. YANG R, Zeng Y, Xu H, Chen Z, et al
    Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.
    Oncol Rep. 2016 Jun 2. doi: 10.3892/or.2016.4845.
    PubMed     Text format     Abstract available


  105. OHNO T, Ohtani M, Suto H, Ohta M, et al
    Effect of green tea catechins on gastric mucosal dysplasia in insulin-gastrin mice.
    Oncol Rep. 2016;35:3241-7.
    PubMed     Text format     Abstract available


    May 2016
  106. SU C, Zhang B, Liu W, Zheng H, et al
    High extracellular pressure promotes gastric cancer cell adhesion, invasion, migration and suppresses gastric cancer cell differentiation.
    Oncol Rep. 2016 May 30. doi: 10.3892/or.2016.4841.
    PubMed     Text format     Abstract available


  107. LI PY, Lv J, Qi WW, Zhao SF, et al
    Tspan9 inhibits the proliferation, migration and invasion of human gastric cancer SGC7901 cells via the ERK1/2 pathway.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4805.
    PubMed     Text format     Abstract available


    April 2016
  108. OUE N, Mukai S, Imai T, Pham TT, et al
    Induction of KIFC1 expression in gastric cancer spheroids.
    Oncol Rep. 2016 Apr 28. doi: 10.3892/or.2016.4781.
    PubMed     Text format     Abstract available


  109. LAN WG, Xu DH, Xu C, Ding CL, et al
    Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Oncol Rep. 2016 Apr 26. doi: 10.3892/or.2016.4771.
    PubMed     Text format     Abstract available


  110. CHANG S, Liu J, Guo S, He S, et al
    HOTTIP and HOXA13 are oncogenes associated with gastric cancer progression.
    Oncol Rep. 2016 Apr 13. doi: 10.3892/or.2016.4743.
    PubMed     Text format     Abstract available


  111. ZHANG J, Liu Y, Zhang J, Cui X, et al
    FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
    Oncol Rep. 2016 Apr 8. doi: 10.3892/or.2016.4736.
    PubMed     Text format     Abstract available


  112. PENG Y, Zhao Q, Zhang H, Han B, et al
    TIPE2, a negative regulator of TLR signaling, regulates p27 through IRF4-induced signaling.
    Oncol Rep. 2016;35:2480-6.
    PubMed     Text format     Abstract available


    March 2016
  113. XU JM, Zhou Y, Gao L, Zhou SX, et al
    Stromal interaction molecule 1 plays an important role in gastric cancer progression.
    Oncol Rep. 2016 Mar 24. doi: 10.3892/or.2016.4704.
    PubMed     Text format     Abstract available


  114. XU Y, Jin X, Huang Y, Dong J, et al
    Inhibition of peritoneal metastasis of human gastric cancer cells by dextran sulphate through the reduction in HIF-1alpha and ITGbeta1 expression.
    Oncol Rep. 2016 Mar 18. doi: 10.3892/or.2016.4693.
    PubMed     Text format     Abstract available


  115. LIN X, Huang Y, Zou Y, Chen X, et al
    Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Oncol Rep. 2016 Mar 17. doi: 10.3892/or.2016.4692.
    PubMed     Text format     Abstract available


  116. LU S, Ma Y, Sun T, Ren R, et al
    Expression of alpha-fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.
    Oncol Rep. 2016 Mar 16. doi: 10.3892/or.2016.4678.
    PubMed     Text format     Abstract available


  117. LI L, Wen XZ, Bu ZD, Cheng XJ, et al
    Paclitaxel enhances tumoricidal potential of TRAIL via inhibition of MAPK in resistant gastric cancer cells.
    Oncol Rep. 2016 Mar 9. doi: 10.3892/or.2016.4666.
    PubMed     Text format     Abstract available


  118. WU Y, Zhang Q, Ruan Z, Yin Y, et al
    Intrinsic effects of gold nanoparticles on proliferation and invasion activity in SGC-7901 cells.
    Oncol Rep. 2016;35:1457-62.
    PubMed     Text format     Abstract available


    February 2016
  119. CAO W, Wei W, Zhan Z, Xie Y, et al
    miR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1.
    Oncol Rep. 2016 Feb 29. doi: 10.3892/or.2016.4643.
    PubMed     Text format     Abstract available


  120. LIU K, Qin YH, Yu JY, Ma H, et al
    3-beta-Epsilonrythrodiol isolated from Conyza canadensis inhibits MKN45 human gastric cancer cell proliferation by inducing apoptosis, cell cycle arrest, DNA fragmentation, ROS generation and reduces tumor weight and volume in mouse xenograft model.
    Oncol Rep. 2016 Feb 3. doi: 10.3892/or.2016.4610.
    PubMed     Text format     Abstract available


  121. ZHANG H, Qu Y, Duan J, Deng T, et al
    Integrated analysis of the miRNA, gene and pathway regulatory network in gastric cancer.
    Oncol Rep. 2016;35:1135-1146.
    PubMed     Text format     Abstract available


  122. GAO L, Xu Z, Wang Y, Sun B, et al
    Anticancer effect of SZC017, a novel derivative of oleanolic acid, on human gastric cancer cells.
    Oncol Rep. 2016;35:1101-1108.
    PubMed     Text format     Abstract available


  123. TAKANO J, Morishita A, Fujihara S, Iwama H, et al
    Galectin-9 suppresses the proliferation of gastric cancer cells in vitro.
    Oncol Rep. 2016;35:851-860.
    PubMed     Text format     Abstract available


    January 2016
  124. GENG Y, Lu X, Wu X, Xue L, et al
    MicroRNA-27b suppresses Helicobacter pylori-induced gastric tumorigenesis through negatively regulating Frizzled7.
    Oncol Rep. 2016 Jan 18. doi: 10.3892/or.2016.4572.
    PubMed     Text format     Abstract available


  125. ZHAO G, Zhu G, Huang Y, Zheng W, et al
    IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Oncol Rep. 2016 Jan 5. doi: 10.3892/or.2016.4544.
    PubMed     Text format     Abstract available


    December 2015
  126. LI C, Liang G, Yao W, Sui J, et al
    Differential expression profiles of long non-coding RNAs reveal potential biomarkers for identification of human gastric cancer.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4531.
    PubMed     Text format     Abstract available


  127. YUAN DD, Zhu ZX, Zhang X, Liu J, et al
    Targeted therapy for gastric cancer: Current status and future directions (Review).
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4528.
    PubMed     Text format     Abstract available


  128. WANG TA, Zhang XD, Guo XY, Xian SL, et al
    3-Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial-mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4511.
    PubMed     Text format     Abstract available


  129. RIBEIRO CH, Kramm K, Galvez-Jiron F, Pola V, et al
    Clinical significance of tumor expression of major histocompatibility complex class I-related chains A and B (MICA/B) in gastric cancer patients.
    Oncol Rep. 2015 Dec 23. doi: 10.3892/or.2015.4510.
    PubMed     Text format     Abstract available


  130. HAYASHI N, Ando Y, Gyawali B, Shimokata T, et al
    Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer.
    Oncol Rep. 2015 Dec 8. doi: 10.3892/or.2015.4475.
    PubMed     Text format     Abstract available


    November 2015
  131. NIE C, Zhou J, Qin X, Shi X, et al
    Reduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803.
    Oncol Rep. 2015 Nov 13. doi: 10.3892/or.2015.4419.
    PubMed     Text format     Abstract available


  132. JING X, Cheng W, Wang S, Li P, et al
    Resveratrol induces cell cycle arrest in human gastric cancer MGC803 cells via the PTENregulated PI3K/Akt signaling pathway.
    Oncol Rep. 2015 Nov 3. doi: 10.3892/or.2015.4384.
    PubMed     Text format     Abstract available


    September 2015
  133. WU J, Zhang XX, Sun QM, Chen M, et al
    beta-asarone inhibits gastric cancer cell proliferation.
    Oncol Rep. 2015 Sep 30. doi: 10.3892/or.2015.4316.
    PubMed     Text format     Abstract available


  134. WEN T, Hou K, Li Z, Li L, et al
    Silencing beta-linked N-acetylglucosamine transferase induces apoptosis in human gastric cancer cells through PUMA and caspase-3 pathways.
    Oncol Rep. 2015 Sep 15. doi: 10.3892/or.2015.4276.
    PubMed     Text format     Abstract available


  135. ZHONG F, Cui D, Tao H, Du H, et al
    IL-17A-producing T cells and associated cytokines are involved in the progression of gastric cancer.
    Oncol Rep. 2015 Sep 7. doi: 10.3892/or.2015.4246.
    PubMed     Text format     Abstract available


  136. WANG RX, Liu H, Xu L, Zhang H, et al
    Involvement of nuclear receptor RZR/RORgamma in melatonin-induced HIF-1alpha inactivation in SGC-7901 human gastric cancer cells.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4238.
    PubMed     Text format     Abstract available


  137. YANG Y, Li M, Yan Y, Zhang J, et al
    Expression of RAP1B is associated with poor prognosis and promotes an aggressive phenotype in gastric cancer.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4234.
    PubMed     Text format     Abstract available


  138. ZHU GC, Gao L, He J, Long Y, et al
    CD90 is upregulated in gastric cancer tissues and inhibits gastric cancer cell apoptosis by modulating the expression level of SPARC protein.
    Oncol Rep. 2015 Sep 1. doi: 10.3892/or.2015.4243.
    PubMed     Text format     Abstract available


    August 2015
  139. LI TF, Qin SH, Ruan XZ, Wang X, et al
    p120-catenin participates in the progress of gastric cancer through regulating the Rac1 and Pak1 signaling pathway.
    Oncol Rep. 2015 Aug 26. doi: 10.3892/or.2015.4226.
    PubMed     Text format     Abstract available


  140. LIU H, Liang S, Yang X, Ji Z, et al
    RNAi-mediated RPL34 knockdown suppresses the growth of human gastric cancer cells.
    Oncol Rep. 2015 Aug 21. doi: 10.3892/or.2015.4219.
    PubMed     Text format     Abstract available


  141. JUN KH, Lee JE, Kim SH, Jung JH, et al
    Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models.
    Oncol Rep. 2015 Aug 10. doi: 10.3892/or.2015.4191.
    PubMed     Text format     Abstract available


  142. GHONEUM M, Felo N
    Selective induction of apoptosis in human gastric cancer cells by Lactobacillus kefiri (PFT), a novel kefir product.
    Oncol Rep. 2015 Aug 6. doi: 10.3892/or.2015.4180.
    PubMed     Text format     Abstract available


    July 2015
  143. GAO XY, Li L, Wang XH, Wen XZ, et al
    Inhibition of sphingosine-1-phosphate phosphatase 1 promotes cancer cells migration in gastric cancer: Clinical implications.
    Oncol Rep. 2015 Jul 30. doi: 10.3892/or.2015.4162.
    PubMed     Text format     Abstract available


  144. DING J, Feng M, Wang F, Wang H, et al
    Targeting effect of PEGylated liposomes modi fi ed with the Arg-Gly-Asp sequence on gastric cancer.
    Oncol Rep. 2015 Jul 22. doi: 10.3892/or.2015.4142.
    PubMed     Text format     Abstract available


  145. ZHAO Z, Song Y, Piao D, Liu T, et al
    Identification of genes and long non-coding RNAs associated with the pathogenesis of gastric cancer.
    Oncol Rep. 2015 Jul 14. doi: 10.3892/or.2015.4129.
    PubMed     Text format     Abstract available


  146. JIANG H, Yu WW, Wang LL, Peng Y, et al
    miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3.
    Oncol Rep. 2015 Jul 1. doi: 10.3892/or.2015.4099.
    PubMed     Text format     Abstract available


    June 2015
  147. YUN M, Rong J, Lin ZR, He YL, et al
    High expression of transforming acidic coiled coil-containing protein 3 strongly correlates with aggressive characteristics and poor prognosis of gastric cancer.
    Oncol Rep. 2015 Jun 30. doi: 10.3892/or.2015.4093.
    PubMed     Text format     Abstract available


  148. LIM SC, Han SI
    Ursodeoxycholic acid effectively kills drug-resistant gastric cancer cells through induction of autophagic death.
    Oncol Rep. 2015 Jun 24. doi: 10.3892/or.2015.4076.
    PubMed     Text format     Abstract available


  149. OKITA Y, Ohira M, Tanaka H, Tokumoto M, et al
    Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer.
    Oncol Rep. 2015 Jun 15. doi: 10.3892/or.2015.4064.
    PubMed     Text format     Abstract available


  150. LEE WS, Kim N, Park YR, Oh HH, et al
    Myeloid cell leukemia-1 promotes epithelial-mesenchymal transition of human gastric cancer cells.
    Oncol Rep. 2015 Jun 8. doi: 10.3892/or.2015.4040.
    PubMed     Text format     Abstract available


  151. BAE JH, Kang MJ, Yang KM, Kim TO, et al
    Epigenetically silenced microRNAs in gastric cancer: Functional analysis and identification of their target genes.
    Oncol Rep. 2015 Jun 5. doi: 10.3892/or.2015.4036.
    PubMed     Text format     Abstract available


  152. HABIB R, Akhtar J, Taqi M, Yu C, et al
    Lentiviral vector-mediated survivin shRNA delivery in gastric cancer cell lines significantly inhibits cell proliferation and tumor growth.
    Oncol Rep. 2015 Jun 5. doi: 10.3892/or.2015.4033.
    PubMed     Text format     Abstract available


  153. LIU SQ, Xu CY, Qin MB, Tan L, et al
    Ginkgo biloba extract enhances chemotherapy sensitivity and reverses chemoresistance through suppression of the KSR1-mediated ERK1/2 pathway in gastric cancer cells.
    Oncol Rep. 2015;33:2871-82.
    PubMed     Text format     Abstract available


  154. CHEN J, Sun D, Chu H, Gong Z, et al
    Screening of differential microRNA expression in gastric signet ring cell carcinoma and gastric adenocarcinoma and target gene prediction.
    Oncol Rep. 2015;33:2963-71.
    PubMed     Text format     Abstract available


    May 2015
  155. LIN L, Jiang H, Huang M, Hou X, et al
    Depletion of histone deacetylase 1 inhibits metastatic abilities of gastric cancer cells by regulating the miR-34a/CD44 pathway.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4010.
    PubMed     Text format     Abstract available


  156. HUAN Y, Wu D, Zhou D, Sun B, et al
    DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-kappaB activity.
    Oncol Rep. 2015 May 28. doi: 10.3892/or.2015.4007.
    PubMed     Text format     Abstract available


  157. WU F, Lv T, Chen G, Ye H, et al
    Epigenetic silencing of DUSP9 induces the proliferation of human gastric cancer by activating JNK signaling.
    Oncol Rep. 2015 May 20. doi: 10.3892/or.2015.3998.
    PubMed     Text format     Abstract available


  158. SUN T, Jia Y, Xiao D
    Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis.
    Oncol Rep. 2015 May 19. doi: 10.3892/or.2015.3994.
    PubMed     Text format     Abstract available


  159. KIM SH, Kang YJ, Sung B, Kim DH, et al
    MHY-449, a novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative, mediates oxidative stress-induced apoptosis in AGS human gastric cancer cells.
    Oncol Rep. 2015 May 18. doi: 10.3892/or.2015.3984.
    PubMed     Text format     Abstract available


  160. ZHANG X, Zheng L, Sun Y, Wang T, et al
    Tangeretin enhances radiosensitivity and inhibits the radiation-induced epithelial-mesenchymal transition of gastric cancer cells.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3982.
    PubMed     Text format     Abstract available


  161. WEN X, Wu JQ, Peng W, Feng JF, et al
    MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
    Oncol Rep. 2015 May 15. doi: 10.3892/or.2015.3981.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: